Updated 02:01 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,868.50 -0.46% CL 85.14 -3.86% BTC 65,305.22 0.00%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,869 −0.46% BTC $65,305 VIX 22.91 +18.70% latest tape · as of 02:01 UTC
The Screen · Healthcare · Medical Care Facilities

Auna SA

AUNA · the NYSE · USD · Market cap $379M · 14,796 employees

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

FAIL · Does not pass the screen
4.59 USD

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price4.59 USD at the 13 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 13 Nov 2026
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $8.62 to $9.18, base estimate $8.62 (screen dated 2026-11-13).

Current read
Distribution ?
Undervalued · screened 2026-11-13
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price4.59 USD
Fair value8.62
Ethical score70.0/100
Value readUndervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-11-04Read Distribution4.51+1.8% to today Markdown gives way to Distribution after a 15% slide in 8 days
2026-10-27Read Markdown5.30-13.4% to today ✓Accumulation gives way to Markdown first Markdown read since October
2026-10-20Read Accumulation5.30-13.4% to today Markdown gives way to Accumulation
2026-09-24Read Markdown5.18-11.4% to today ✓Accumulation gives way to Markdown with volume flow in agreement

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Auna SA holds its Distribution at $4.59. The statistical read favours the sellers, held for 94 days.

As held on the ledger · 2026-11-13
PhaseDistribution · caution
Quantitative stateThe statistical read favours the sellers, held for 94 days
Price at the screen$4.59
Valuation19.19 trailing · 4.67 forward price to earnings
Values screenFAIL · score 70.0
Beta0.61
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 50.10% Below 33% Interest-bearing debt is 50.1% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.01% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 18.88% Below 49% Money owed to the company is 18.9% of assets, under the 49% limit. Pass
Revenue purity 0.43% Below 5% Only 0.4% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Auna's business is in a permissible area, but its interest-bearing debt is about 50% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when AUNA's ethical verdict changes

Today AUNA does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 47% discount to our $8.62 fair value, none competitive moat, 13.00% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

8.62Conservative8.62Base case9.18Growth case 4.59Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 46.8% discount to the base estimate.

The Street's Range
5.00Street low 6.90Street average 9.00Street high 4.59Price

Third-party analyst targets: 7 covering, consensus Buy. The average target sits +50% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $8.62, with a range of $8.62 to $9.18, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it stands out

A 13%-growth business trading at just 4.7x forward earnings, with a none competitive moat. That is a 47% discount to our $8.62 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 7 analysts rate it Buy with a $6.90 average target, about 50% above the screened price.

The fundamentals · plain-English read
Forward P/E4.7xcheap for a company growing this fast
Trailing P/E19.2xreasonably valued
EPS, trailing0.27
EPS, forward1.11
Revenue growth+13.0%steady growth
Profit margin1.5%barely profitable
Return on equity4.6%a modest return on shareholder capital
FCF yield61.05%
Debt to equity2.02heavy leverage: higher risk if revenue softens
Current ratio1.09adequate liquidity, worth monitoring
Beta0.61steadier than the market
Short interest, float0.03%
52-week range4.09 - 6.85
MoatNONE
Market cap$379M
Employees14,796

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Luxembourg and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

AUNA trades on the NYSE (the company is based in Luxembourg). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-15 Distribution $4.59 +1.8% Entry 12

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (7 analysts) rates it buy, with a mean price target of $7.

2026-11-04 Distribution · changed $4.51 -14.9% Entry 11

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (7 analysts) rates it buy, with a mean price target of $7.

2026-10-27 Markdown · changed $5.30 +0.0% Entry 10

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (7 analysts) rates it buy, with a mean price target of $7.

2026-10-20 Accumulation · changed $5.30 +3.5% Entry 9

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (7 analysts) rates it buy, with a mean price target of $7.

2026-10-13 Markdown $5.12 -1.2% Entry 8

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (7 analysts) rates it buy, with a mean price target of $7.

2026-10-02 Markdown $5.18 +0.0% Entry 7

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (7 analysts) rates it buy, with a mean price target of $7.

2026-09-24 Markdown · changed $5.18 +1.2% Entry 6

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (7 analysts) rates it buy, with a mean price target of $7.

2026-08-22 Accumulation · changed $5.12 +0.0% Entry 5

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (7 analysts) rates it buy, with a mean price target of $7.

2026-07-22 Markup · changed $5.12 +3.9% Entry 4

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (7 analysts) rates it buy, with a mean price target of $7.

2026-07-18 Distribution $4.93 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (7 analysts) rates it buy, with a mean price target of $7.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in AUNA's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $5.05 -5.2% · $949 -5.2%
2 months $5.88 -18.5% · $815 -18.5%
3 months $4.98 -3.8% · $962 -3.8%
6 months $4.71 +1.7% · $1,017 +1.7%
1 year $6.35 -24.6% · $754 -24.6%
2 years $7.83 -38.8% · $612 -38.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever AUNA does next, these words stay.

Auna SA · AUNA · Distribution · $4.59
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.